Hemostats, sealants, and adhesives III: A new update as well as cost and regulatory considerations for components of the surgical toolbox

Transfusion

Volumn 52, Issue 10, 2012, Pages 2243-2255

  Spotnitz, William D ^a   Burks, Sandra ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIVE AGENT; CYANOACRYLATE; ENDOAVITENE; FIBRIN GLUE; FLOSEAL; GELFOAM; HEMOSTATIC AGENT; HUMAN SERUM ALBUMIN; MACROGOL; MICROCRYSTALLINE COLLAGEN; OXIDIZED REGENERATED CELLULOSE; RECOMBINANT THROMBIN; SEALANT; THROMBIN; UNCLASSIFIED DRUG;

BIOCOMPATIBILITY; CLINICAL PRACTICE; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG SAFETY; FORCED EXPIRATORY VOLUME; FOREIGN BODY REACTION; HEALTH CARE; HEALTH CARE COST; HEALTH CARE QUALITY; HUMAN; KIDNEY FUNCTION; LIQUORRHEA; MULTICENTER STUDY (TOPIC); REVIEW; RISK FACTOR; STORAGE TEMPERATURE; SURGICAL TRAINING; TIDAL VOLUME; VISCOSITY; WOUND CLOSURE;

ANIMALS; COLLAGEN; COST SAVINGS; COSTS AND COST ANALYSIS; CYANOACRYLATES; DRUG APPROVAL; DRUG CONTAMINATION; EQUIPMENT CONTAMINATION; FIBRINOGEN; FORECASTING; GELATIN SPONGE, ABSORBABLE; GLUTARAL; HEMOSTATICS; HUMANS; INFECTION CONTROL; INVENTIONS; POLYETHYLENE GLYCOLS; THROMBIN; TISSUE ADHESIVES;

EID: 84868301417     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03707.x     Document Type: Review

References (60)

1. Rao A, Kynaston J, MacDonald ER, Ahmed I,. Patient preferences for surgical techniques: should we invest in new approaches? Surg Endosc 2010; 24: 3016-25.
2. Lamadé W, Friedrich C, Ulmer C, Basar T, Weiss H, Thon KP,. Impact of body image on patients' attitude towards conventional, minimal invasive, and natural orifice surgery. Langenbecks Arch Surg 2011; 396: 331-6.
3. Bucher P, Pugin F, Ostermann S, Ris F, Chilcott M, Morel P,. Population perception of surgical safety and body image trauma: a plea for scarless surgery? Surg Endosc 2011; 25: 408-15.
4. Ballantyne GH, Farkas D, Laker S, Wasielewski A,. Short-term changes in insulin resistance following weight loss surgery for morbid obesity: laparoscopic adjustable gastric banding versus laparoscopic Roux-en-Y gastric bypass. Obes Surg 2006; 16: 1189-97.
5. Varadarajulu S, Tamhane A, Drelichman ER,. Patient perception of natural orifice transluminal endoscopic surgery as a technique for cholecystectomy. Gastrointest Endosc 2008; 67: 854-60.
6. Atug F, Castle EP, Woods M, Srivastav SK, Thomas R, Davis R,. Transperitoneal versus extraperitoneal robotic-assisted radical prostatectomy: is one better than the other? Urology 2006; 68: 1077-81.
7. Bernard AC, Davenport DL, Chang PK, Vaughan TB, Zwischenberger JB,. Intraoperative transfusion of 1 U to 2 U packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patients. J Am Coll Surg 2009; 208: 931-7.
8. Martinez V, Monsaingeon-Lion A, Cherif K, Judet T, Chauvin M, Fletcher D,. Transfusion strategy for primary knee and hip arthroplasty: impact of an algorithm to lower transfusion rates and hospital costs. Br J Anaesth 2007; 99: 794-800.
9. Earley AS, Gracias VH, Haut E, Sicoutris CP, Wiebe DJ, Reilly PM, Schwab CW,. Anemia management program reduces transfusion volumes, incidence of ventilator-associated pneumonia, and cost in trauma patients. J Trauma 2006; 61: 1-5.
10. Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Angelini GD,. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 2007; 116: 2544-52.
11. Koch CG, Li L, Sessler DI, Figueroa P, Hoeltge GA, Mihaljevic T, Blackstone EH,. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008; 358: 1229-39.
12. Weinberg JA, McGwin G Jr, Marques MB, Cherry SA 3rd, Reiff DA, Kerby JD, Rue LW 3rd,. Transfusions in the less severely injured: does age of transfused blood affect outcomes? J Trauma 2008; 65: 794-8.
13. Wittkowsky AK,. Novel oral anticoagulants and their role in clinical practice. Pharmacotherapy 2011; 31: 1175-91.
14. Douketis JD,. Pharmacologic properties of the new oral anticoagulants: a clinician-oriented review with a focus on perioperative management. Curr Pharm Des 2010; 16: 3436-41.
15. Su YH, Yeh CC, Lee CY, Lin MW, Kuan CH, Lai IR, Chen CN, Lin HM, Lee PH, Lin MT,. Acute surgical treatment of perforated peptic ulcer in the elderly patients. Hepatogastroenterology 2010; 57: 1608-13.
16. Kurian A, Suryadevara S, Ramaraju D, Gallagher S, Hofmann M, Kim S, Zebley M, Fassler S,. In-hospital and 6-month mortality rates after open elective vs. open emergent colectomy in patients older than 80 years. Dis Colon Rectum 2011; 54: 467-71.
17. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ,; PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011; 364: 2187-98.
18. Lidor AO, Chang DC, Feinberg RL, Steele KE, Schweitzer MA, Franco MM,. Morbidity and mortality associated with antireflux surgery with or without paraesophogeal hernia: a large ACS NSQIP analysis. Surg Endosc 2011; 25: 3101-8.
19. Dorman RB, Abraham AA, Al-Refaie WB, Parsons HM, Ikramuddin S, Habermann EB,. Bariatric surgery outcomes in the elderly: an ACS NSQIP study. J Gastrointest Surg 2012; 16: 35-44.
20. Campbell PR,. Population projections for states by age, sex, race, and Hispanic origin: 1995 to 2025. U.S. Bureau of the Census, Population Division, 1996, PPL-47.
21. Abelson R,. Health insurance costs rising sharply this year, study shows. New York Times. 2011, National Edition, September 28, page A1.
22. Spotnitz WD, Burks S,. Hemostats, sealants, and adhesives: components of the surgical toolbox. Transfusion 2008; 48: 1502-16.
23. Spotnitz WD, Burks S,. State-of-the-art review: hemostats, sealants, and adhesives II: update as well as how and when to use the components of the surgical toolbox. Clin Appl Thromb Hemost 2010; 16: 497-514.
24. Baxter Healthcare Corp. Package insert. Tachosil, Baxter. 2010. [cited 2012 Apr 26]. Availabe from: URL: http://www.fda.gov/downloads/ BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/ FractionatedPlasmaProducts/UCM207483.pdf
25. Horowitz B, Busch M,. Estimating the pathogen safety of manufactured human plasma products: application to fibrin sealants and to thrombin. Transfusion 2008; 48: 1739-53.
26. Joch C,. The safety of fibrin sealants. Cardiovasc Surg 2003; 11 Suppl 1: 23-8.
27. Hino M, Ishiko O, Honda KI, Yamane T, Ohta K, Takubo T, Tatsumi N,. Transmission of symptomatic parvovirus B19 infection by fibrin sealant used during surgery. Br J Haematol 2000; 108: 194-5.
28. Kawamura M, Sawafuji M, Watanabe M, Horinouchi H, Kobayashi K,. Frequency of transmission of human parvovirus B19 infection by fibrin sealant used during thoracic surgery. Ann Thorac Surg 2002; 73: 1098-100.
29. Maisano F, Kjaergãrd HK, Bauernschmitt R, Pavie A, Rábago G, Laskar M, Marstein JP, Falk V,. TachoSil surgical patch versus conventional haemostatic fleece material for control of bleeding in cardiovascular surgery: a randomised controlled trial. Eur J Cardiothorac Surg 2009; 36: 708-14.
30. Erb MA, Claus T, Hartrumpf M, Bachmann S, Albes JM,. The use of Tachosil surgical patch or fibrin glue in coronary artery surgery does not affect quality of anastomosis or provoke postoperative adhesions in pigs. Eur J Cardiothorac Surg 2009; 36: 703-7.
31. Neomend, Inc. Package insert. Progel, Neomend. 2011. [cited 2012 Apr 26]. Available from: URL: http://www.fda.gov/ohrms/dockets/ac/08/briefing/2008- 4360b1-08-Proposed%20Package%20Insert.pdf
32. Allen MS, Wood DE, Hawkinson RW, Harpole DH, McKenna RJ, Walsh GL, Vallieres E, Miller DL, Nichols FC 3rd, Smythe WR, Davis RD,; 3M Surgical Sealant Study Group. Prospective randomized study evaluating a biodegradable polymeric sealant for sealing intraoperative air leaks that occur during pulmonary resection. Ann Thorac Surg 2004; 77: 1792-801.
33. Saif R, Jacob M, Robinson S, Amer A, Kei-Hui D, Sen G, Manas D, White S,. Use of fibrin-based sealants and gelatin-matrix hemostats in laparoscopic liver surgery. Surg Laparosc Endosc Percutan Tech 2011; 21: 131-41.
34. Covidien. Package insert. Duraseal Exact, Covidien. 2009-4437b 1-09. 2009. [cited 2012 Apr 26]. Available from: URL: http://www.fda.gov/downloads/ AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/ MedicalDevicesAdvisoryCommittee/NeurologicalDevicesPanel/UCM162638.pdf
35. Covidien. New, improved formulation provides low swell, watertight closure during spinal surgery. News release. David T. Young. Covidien Public Relations. April 13, 2011.
36. Kim KD, Wright NM,. Polyethylene glycol hydrogel spinal sealant (DuraSeal Spinal Sealant) as an adjunct to sutured dural repair in the spine: results of a prospective, multicenter, randomized controlled study. Spine (Phila Pa 1976) 2011; 36: 1906-12.
37. Ethicon, Inc. Package insert. Omnex, Ethicon, J&J. 2010. [cited 2012 Apr 26]. Available from: URL: http://www.ethicon360emea.com/sites/default/files/ products/Omnex%20IFU-0.pdf
38. Schenk WG 3rd, Spotnitz WD, Burks SG, Lin PH, Bush RL, Lumsden AB,. Absorbable cyanoacrylate as a vascular hemostatic sealant: a preliminary trial. Am Surg 2005; 71: 658-61.
39. Lumsden AB, Heyman ER,; Closure Medical Surgical Sealant Study Group. Prospective randomized study evaluating an absorbable cyanoacrylate for use in vascular reconstructions. J Vasc Surg 2006; 44: 1002-9.
40. Krause D,. FDA/CDRH regulatory history of tissue adhesives, sealants and glues. Slide presentation. FDA First Tissue Adhesives Symposium, FDA White Oak Campus, Building 2 A-2031, 10903 New Hampshire Avenue, Silver Spring, MD, 20993. September 26 & 27, 2011.
41. Ethicon, Inc. Instructions for use. Dermabond Advanced, Ethicon/J&J. 2011. [cited 2012 Apr 26]. Available from: URL: http://www.ethicon360.com/sites/ default/files/products/Dermabond-IFU-2011.pdf
42. Chemence Medical Products, Inc. Instructions for use. Derma Flex QS, Chemence. 2010. [cited 2012 Apr 26]. Available from: URL: http://www. medicalglue.com/ifu.html
43. Advanced Medical Solutions Ltd. Instructions for use. Liquiband Flex, Advanced Medical Solutions. 2011. [cited 2012 Apr 26]. Available from: URL: http://us.liquiband.com/media/30344/06-0401-01-pids-liquiband-flex-awk.pdf
44. Medline Industries. Brochure. Octyseal, Medline Industries. 2011. [cited 2012 Apr 26]. Available from: URL: https://www.medline.com/irj/servlet/prt/ portal/prtroot/pcd!3aportal-content!2fmedline!2fGlobal!2fPublicDocs/ publicdocuments/Medline%20Documents/Marketing%20Materials/MarketingDocuments-N- Z/Octylseal%20Brochure%20MKT211211%20LIT427.pdf
45. Adhezion Biomedical. Professional use reference. Surgiseal, Adhezion Biomedical. 2010. [cited 2012 Apr 26]. Available from: URL: http://www.adhezion. com/docs/products/professional/surgical-solutions/surgiseal/default.aspx
46. Ethicon, Inc. Instructions for use. Dermabond Prineo, Ethicon/J&J. 2010. [cited 2012 Apr 26]. Available from: URL: http://www.ethicon360.com/sites/ default/files/products/DERMABOND-PRINEO-IFU-new-001-0-0.pdf
47. Advanced Medical Solutions Ltd. Instructions for use. Liquiband, Advanced Medical Solutions. 2010. [cited 2012 Apr 26]. Available from: URL: http://www.admedsol.com/Doc/liquibandFLOW-small.pdf
48. Quinn JV, Drzewiecki A, Li MM, Stiell IG, Sutcliffe T, Elmslie TJ, Wood WE,. A randomized, controlled trial comparing a tissue adhesive with suturing in the repair of pediatric facial lacerations. Ann Emerg Med 1993; 22: 1130-5.
49. Quinn J, Wells G, Sutcliffe T, Jarmuske M, Maw J, Stiell I, Johns P,. A randomized trial comparing octylcyanoacrylate tissue adhesive and sutures in the management of lacerations. JAMA 1997; 277: 1527-30.
50. Toriumi DM, O'Grady K, Desai D, Bagal A,. Use of octyl-2-cyanoacrylate for skin closure in facial plastic surgery. Plast Reconstr Surg 1998; 102: 2209-19.
51. Krishnamoorthy B, Najam O, Khan UA, Waterworth P, Fildes JE, Yonan N,. Randomized prospective study comparing conventional subcuticular skin closure with Dermabond skin glue after saphenous vein harvesting. Ann Thorac Surg 2009; 88: 1445-9.
52. Singer AJ, Giordano P, Fitch JL, Gulla J, Ryker D, Chale S,. Evaluation of a new high-viscosity octylcyanoacrylate tissue adhesive for laceration repair: a randomized, clinical trial. Acad Emerg Med 2003; 10: 1134-7.
53. Huemer GM, Schmidt M, Helml GH, Shafighi M, Dunst-Huemer KM,. Effective wound closure with a new two-component wound closure device (prineo⢠) in excisional body-contouring surgery: experience in over 200 procedures. Aesthetic Plast Surg 2012; 36: 382-6.
54. Porter ME,. The five competitive forces that shape strategy. Harv Bus Rev 2008; 86: 78-93, 137.
55. Alving BM, Weinstein MJ, Finlayson JS, Menitove JE, Fratantoni JC,. Fibrin sealant: summary of a conference on characteristics and clinical uses. Transfusion 1995; 35: 783-90.
56. US Food and Drug Administration. Guidance for industry: efficacy studies to support marketing of fibrin sealant products manufactured for commercial use. US Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research (CBER). May 20, 1999.
57. US Food and Drug Administration. Guidance for industry and FDA staff: Class II special controls guidance document: tissue adhesive for the topical approximation of skin. US Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiologic Health and Plastic and Reconstructive Surgery Devices Branch, Division of General, Restorative, and Neurological Devices, Office of Device Evaluation. May 30, 2008.
58. US Food and Drug Administration. Draft guidance for industry and FDA staff: Class II special controls guidance document: absorbable hemostatic device. US Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiologic Health and Plastic and Reconstructive Surgery Devices Branch, Division of General, Restorative, and Neurological Devices, Office of Device Evaluation. October 31, 2006.
59. Palm MD, Altman JS,. Topical hemostatic agents: a review. Dermatol Surg 2008; 34: 431-45.
60. Achneck HE, Sileshi B, Jamiolkowski RM, Albala DM, Shapiro ML, Lawson JH,. A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. Ann Surg 2010; 251: 217-28.